The inhibitory effect of OGT gene expression on the level of tau phosphorylation

Progress in Biochemistry and Biophysics

Volumn 36, Issue 3, 2009, Pages 346-352

  Yang, Jiang Yong ^a   Gu, Jian Lan ^a   Shi, Jian Hua ^a   Liu, Fei ^a   Shen, Qin ^a  

^a NANTONG MEDICAL COLLEGE   (China)

Author keywords

Alzheimer's disease; OGT; RNA interference; Tau

Indexed keywords

EID: 67650964022     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2008.00326     Document Type: Article

References (17)

1. Pérez M, Hernández F, Gómez-Ramos A, et al. Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. Eur J Biochem, 2002, 269(5): 1484-1489
2. Fath T, Eidenmuller J, Brandt R. Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J Neurosci, 2002, 22(22): 9733-9741
3. Rapoport M, Dawson H N, Binder L I, et al. Tau is essential to beta-amyloid-induced neurotoxic¡ty. Proc Natl Acad Sci USA, 2002, 99(9): 6364-6369
4. Jackson G R, Wiedau-Pazos M, Sang T K, et al. Human Wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in drosophila. Neuron, 2002, 34(4): 509-519
5. Hart G W. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Biochem, 1997, 66(1): 315-335
6. Lefebvre T, Ferreira S, Dupont-Wallois L, et al. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins-a role in nuclear localization. Biochim Biophys Acta, 2003, 1619(2): 167-176
7. Liu F, Iqbal K, Grundke-Iqbal I, et al. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc Natl Acad Sci USA, 2004, 101(29): 10804-10809
8. Shi J, Li X, Lu F. Prog Biochem Biophys, 2006, 33(7): 647-652
9. Gong C X, Liu F, Grundke-Iqbal I, et al. Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: A therapeutic target. J Biomed Biotechnol, 2006, 2006(3): 31825
10. Mosconi L, Brys M, Glodzik S L, et al. Early detection of Alzheimer's disease using neuroimaging. Exp Gerontol, 2007, 42 (1-2): 129-138
11. Bokde A L, Teipel S J, Drzezgã A, et al. Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease. Dement Geriatr Cogn Disord, 2005, 20(6): 352-357
12. Hoyer S. Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications. Adv Exp Med Biol, 2004, 541(7): 135-152
13. Lefebvre T, Ferreira S, Dupont-Wallois L, et al. Evidence of a balance between phosphoiylation and O-GlcNAc glycosylation of Tau proteins-a role in nuclear localization. Biochim Biophys Acta, 2003, 1619(2): 167̃ 176
14. Berrrand J R, Pottier M, Vekris A, et al. Comparison of antisense oligonucleotieds and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun, 2002, 296(4): 1000̃1004
15. Alonso Adel C, Mederlyova A, Novak M, et al. Promotion of hyperphosphorylation by frontotemporal dementia taumutations. J Biol Chem, 2004, 279(33): 34878̃34881
16. Abraha, Ghoshal N, Gamblin T C, et al. C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J Cell Sci, 2000, 113 (21): 3734-3745
17. Haase C, Stieler J, Arendt T, et al. Pseudophosphorylation of tau protein alters its ability for self aggregation. J Neurochem, 2004, 88 (6): 1509-1520